Skip to main content

Table 4 Outcomes

From: Management and endovascular therapy of ureteroarterial fistulas: experience from a single center and review of the literature

Case Patient Technical success Early clinical success Periprocedural complication Stent thrombosis (days) Recurrent bleeding (days) Follow-up data
1 1 yes yes no no uneventful at 4 days
2 2 yes yes no no uneventful at 1 days
3 3 yes yes Not fully unfolded stent yes (2) yes (229) death at 229 days due to recurrent hemorrhage
4 4 yes yes no no uneventful at 3 days
5 5 yes yes no no uneventful at 69 days
6 6 yes yes no no uneventful at 186 days
7 7 yes no no yes (8) alive at 11 days
8 8 yes yes no no uneventful at 1390 days
9 9 yes yes no no uneventful at 846 days
10 10 yes yes no no uneventful at 1237 days
11 11 yes no no yes (13) alive at 763 days
12 12 yes yes Closure device failure yes (1) no alive at 220 days
13 13 yes yes no no uneventful at 1984 days
14 14 yes yes yes (58) no alive at 3269 days
15 15 yes yes no no alive at 187 days
16 16 yes no no yes (8) death at 576 days due to underlying disease
17 15 yes yes no no alive at 147 days
Total (%)   17 (100%) 14 (82.4%) 2 (11.8%) 3 (17.7%) 4 (23.5%) Mean follow-up 654 (Range: 1–1984) days